Pharmaceutical Contract Manufacturing — All Dosage Forms & Major Therapeutic Classes
From antibiotic suspensions and analgesic tablets to pediatric syrups and nasal sprays — Saar Biotech's fully segregated, Schedule M compliant facility covers the complete B2B pharma manufacturing spectrum.
Pharmaceutical Contract Manufacturing — By Dosage Form
Our modern Baddi facility operates dedicated, physically segregated manufacturing lines for each distinct dosage class — oral liquids, solid orals, dry syrups, and topicals — guaranteeing absolute batch purity and zero risk of cross-contamination.
View All Products
Third-party contract manufacturing of DCGI-approved oral suspensions in Baddi, India — …
Explore Suspensions
Third-party contract manufacturing of DCGI-approved pharmaceutical syrups in Baddi, India …
Explore Syrups
Pharmaceutical Contract Manufacturing by Therapeutic Category
Saar Biotech serves B2B pharma partners across 9+ major therapeutic categories — with specialized formulation expertise, dedicated raw material sourcing, and stringent DCGI-compliant QA protocols for each area. All manufactured under WHO-GMP standards in Baddi, India.
Antibiotics
High-demand antibiotic formulations for community infections, pediatric use, and hospital supply chains across India — a consistently high-volume B2B segment.
Analgesics & Anti-Inflammatory
Fast-acting NSAID and analgesic formulations for acute pain, fever management, and musculoskeletal conditions — one of the highest-repeat B2B categories.
Gastroenterology
Antacid suspensions, proton pump inhibitors, and mucosal protective agents for acid reflux, GERD, and functional dyspepsia — high prescription frequency.
Pediatrics
Specially formulated pediatric drops, syrups, and suspensions with ideal taste-masking, calibrated dosing, and child-safe pack formats for young patients.
Respiratory
Bronchodilator syrups, nasal sprays, and expectorant combinations for asthma, COPD, and seasonal respiratory conditions — a rapidly growing category in India.
Vitamins & Nutraceuticals
High-efficacy vitamin and nutraceutical formulations in oral drops, shots, and suspension formats for deficiency management and wellness brands.
Dermatology & Topicals
Premium topical formulations — creams, ointments, and gels — for dermatological conditions, musculoskeletal pain, and cosmetic therapeutic applications.
Gynaecology
Hormonal, iron, and folic acid formulations for antenatal care, iron-deficiency anaemia management, and women's health brands in India.
ENT & Nasal
Nasal spray and ENT formulations including isotonic saline, antihistamines, and corticosteroid sprays for allergic rhinitis, sinusitis, and nasal congestion.
B2B Manufacturing FAQs — Dosage Forms & Therapeutic Categories
Common questions from pharma marketing companies and B2B partners looking to start contract manufacturing across multiple product categories in India.
Start Your EnquirySaar Biotech’s WHO-GMP certified facility in Baddi, India manufactures Oral Liquids (Syrups, Suspensions, Drops), Dry Syrups, Tablets (plain, film-coated, enteric-coated, SR), Capsules, Topical Ointments & Gels, and Nasal & Oral Sprays. Each dosage form has a dedicated, physically segregated manufacturing block to prevent cross-contamination and ensure batch purity.
We cover a comprehensive range of therapeutic areas including Antibiotics, Analgesics & Anti-Inflammatory, Gastroenterology, Pediatrics, Respiratory, Vitamins & Nutraceuticals, Dermatology & Topicals, Gynaecology, and ENT / Nasal formulations — all manufactured under DCGI and Schedule M guidelines.
Yes. Our facility is organized both by dosage form (separate liquid, solid, and topical lines) and by therapeutic class (segregated Beta-Lactam and Non-Beta-Lactam blocks). Whether you need an antibiotic suspension, a pediatric vitamin syrup, or a topical analgesic gel, we have the specialized infrastructure and QA protocols in place.
MOQ depends on dosage form and pack size. For suspensions and syrups, pilot MOQ starts at 5,000–10,000 bottles. For tablets and capsules, pilot batches start at 25,000–50,000 units. We offer flexible pilot batches for new brand launches so you can test the Indian market before committing to large volumes.
Simply share your product brief — the molecule, strength, dosage form, pack size, and target volume — via our enquiry form or WhatsApp. Our team responds with a detailed quotation and regulatory roadmap within 24 hours. We handle DCGI licensing documentation, brand artwork, and batch COA issuance end-to-end.
Ready to start your manufacturing partnership?
Share your dosage form, therapeutic area, molecule, and target volume — our team will respond with a quotation and roadmap within 24 hours.